{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:18:15Z","timestamp":1792793895263,"version":"4.5.0"},"reference-count":355,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZDZX0039"],"award-info":[{"award-number":["2025ZDZX0039"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010822","name":"Science and Technology Bureau of Chengdu","doi-asserted-by":"publisher","award":["2026-YF05-00796-SN"],"award-info":[{"award-number":["2026-YF05-00796-SN"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119888","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:25:26Z","timestamp":1787815526000},"page":"119888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nanomaterial-based drug delivery systems: From intelligent delivery to clinical translation and precision nanomedicine"],"prefix":"10.1016","volume":"203","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7512-4225","authenticated-orcid":false,"given":"Shengbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119888_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3724\/zdxbyxb-2022-0084","article-title":"Nano-drug delivery system for the treatment of acute myelogenous leukemia","volume":"51","author":"Zhang","year":"2022","journal-title":"J. Zhejiang Univ. (Med. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119888_bib3","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1016\/j.apsb.2023.05.018","article-title":"Current research trends of nanomedicines","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119888_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1039\/D4PM00176A","article-title":"Advances in liposomal nanotechnology: from concept to clinics","volume":"1","author":"Senjab","year":"2024","journal-title":"RSC Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib5","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s13346-024-01608-8","article-title":"A journey through the history of PEGylated drug delivery nanocarriers","volume":"14","author":"L\u00f3pez-Estevez","year":"2024","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib9","article-title":"Advancements in nanostructured drug delivery systems: Innovations in targeted therapy and multifunctional nanomaterials","volume":"9","author":"Kumar","year":"2026","journal-title":"Nanotechnol"},{"key":"10.1016\/j.biopha.2026.119888_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2004.07.019","article-title":"The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs","volume":"284","author":"Kipp","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: From concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-025-02670-z","article-title":"Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems","volume":"42","author":"Razzaq","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2026.119888_bib13","first-page":"99","article-title":"Stimuli-responsive nanocarriers for drug delivery","author":"Chountoulesi","year":"2020","journal-title":"Nanomater. Clin. Appl. Case Stud. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib14","unstructured":"Cancer nanomedicine: Progress, challenges and opportunities, Nat. Rev. Cancer (n.d.). https:\/\/www.nature.com\/articles\/nrc.2016.108."},{"key":"10.1016\/j.biopha.2026.119888_bib15","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1021\/acsnano.5b03569","article-title":"Accelerating the Translation of Nanomaterials in Biomedicine","volume":"9","author":"Mitragotri","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib16","doi-asserted-by":"crossref","unstructured":"Challenging paradigms in tumour drug delivery, Nat. Mater. 19 (2020) 477. https:\/\/doi.org\/10.1038\/S41563-020-0676-X.","DOI":"10.1038\/s41563-020-0676-x"},{"key":"10.1016\/j.biopha.2026.119888_bib17","article-title":"Perspectives for improving the tumor targeting of nanomedicine via the epr effect in clinical tumors","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27052253","article-title":"From nanoparticle design to clinical translation in cancer therapy","volume":"27","author":"Puiggal\u00ed","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib20","doi-asserted-by":"crossref","unstructured":"Q&A Translational Cancer Nanomedicine, Nat. Commun. 16 (2025) 8288. https:\/\/doi.org\/10.1038\/S41467-025-63488-X.","DOI":"10.1038\/s41467-025-63488-x"},{"key":"10.1016\/j.biopha.2026.119888_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/colloids10010007","article-title":"Lipid-Based Colloidal Nanocarriers for Site-Specific Drug Delivery","volume":"10","author":"Shameli","year":"2026","journal-title":"Colloids Interfaces"},{"key":"10.1016\/j.biopha.2026.119888_bib22","first-page":"1","article-title":"Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective","volume":"4","author":"Gabizon","year":"2025","journal-title":"BMJ Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119888_bib23","first-page":"56","article-title":"Liposome-based drug delivery systems: from laboratory research to industrial production\u2014instruments and challenges","volume":"56","author":"Nicole Radu","year":"2025","journal-title":"ChemEngineering"},{"key":"10.1016\/j.biopha.2026.119888_bib24","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119888_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102757","article-title":"Liposomes as biocompatible and smart delivery systems \u2013 the current state","volume":"309","author":"Dymek","year":"2022","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases \u2014 advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119888_bib28","article-title":"Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo","volume":"27","author":"Zhang","year":"2024","journal-title":"IScience"},{"key":"10.1016\/j.biopha.2026.119888_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s43246-026-01073-5","article-title":"Engineering the biophysical properties of lipid nanostructures for drug delivery","volume":"7","author":"Menge","year":"2026","journal-title":"Commun. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2024.04.010","article-title":"Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives","volume":"180","author":"Souto","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2026.119888_bib31","first-page":"1","article-title":"Reprogramming mRNA Delivery Tropism via Nitrogen-To-Sulfur Substitution in Ionizable Lipids","volume":"09471","author":"Duan","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2026.119888_bib33","article-title":"A novel machine learning framework-based rapid screening of ionizable lipids in LNPs for highly-efficient mRNA expression","author":"Duan","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119888_bib34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","article-title":"Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry","volume":"23","author":"Li","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib36","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1039\/D4CS00891J","article-title":"Engineered multi-domain lipid nanoparticles for targeted delivery","volume":"54","author":"Liu","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119888_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2026.1735885","article-title":"Regulatory framework for polymer-based nanotherapeutics in clinical translation","volume":"14","author":"Stucchi","year":"2026","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib39","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.2147\/IJN.S460047","article-title":"Biopolymer-based nanomedicine for cancer therapy: opportunities and challenges","volume":"19","author":"Wu","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib40","article-title":"Sequence-encoded bioactive protein-multiblock polymer conjugates via quantitative one-pot iterative living polymerization","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-59136-z","article-title":"Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing","volume":"16","author":"Vlasova","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48442-7","article-title":"Enhancing in vivo cell and tissue targeting by modulation of polymer nanoparticles and macrophage decoys","volume":"15","author":"Piotrowski-Daspit","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/pharmaceutics18060674","article-title":"Polymeric Nano Drug Delivery Systems for Overcoming Tumor Microenvironment-Mediated Drug Resistance","volume":"18","author":"Kang","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib44","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1039\/D4BM00224E","article-title":"Recent advances in nanogels for drug delivery and biomedical applications","volume":"12","author":"Vashist","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib45","article-title":"Recent Developments in Nanoparticle-Hydrogel Hybrid Materials for Controlled Release","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci. (Weinh. Baden. -Wurtt. Ger."},{"key":"10.1016\/j.biopha.2026.119888_bib46","article-title":"Recent progress in multifunctional theranostic inorganic nanomaterials for cancer diagnostic imaging and therapy","volume":"8","author":"Parthasarathy","year":"2025","journal-title":"Nanotechnol"},{"key":"10.1016\/j.biopha.2026.119888_bib47","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1039\/D5RA00728C","article-title":"Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review","volume":"15","author":"Ghazi","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115847","article-title":"Magnetic Nanoparticles for Biomedical and Imaging Applications","volume":"25","author":"Konnova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib49","article-title":"Magnetic Hyperthermia with Iron Oxide Nanoparticles: From Toxicity Challenges to Cancer Applications","volume":"15","author":"Baldea","year":"2025","journal-title":"Nanomater. (Basel Switz."},{"key":"10.1016\/j.biopha.2026.119888_bib50","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s44411-026-00501-9","article-title":"Magnetic Nanoparticles in Cancer Therapy: Targeted Drug Delivery, Magnetic Hyperthermia, and Photo-Based Modalities","volume":"127","author":"Mutlu","year":"2026","journal-title":"Bratisl. Med. J."},{"key":"10.1016\/j.biopha.2026.119888_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJN.S384343","article-title":"Inorganic Nanoparticles-Based Systems in Biomedical Applications of Stem Cells: Opportunities and Challenges","volume":"18","author":"Ma","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib52","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.7150\/thno.131621","article-title":"From bench to bedside: the promise and roadblocks of extracellular vesicle therapeutics","volume":"16","author":"Zhang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119888_bib53","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11095-024-03757-4","article-title":"Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles","volume":"41","author":"Takakura","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2025.11.005","article-title":"Comparison of technologies for manufacturing extracellular vesicles for therapeutic applications","volume":"44","author":"Uman","year":"2026","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70220","article-title":"From Lab to Industry: Advancing the Translational Potential of Extracellular Vesicles Through the ISEV Translation, Regulation and Advocacy Committee (ISEV-TRA)","volume":"15","author":"Gurriaran-Rodriguez","year":"2026","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biopha.2026.119888_bib56","article-title":"Beyond Extracellular Vesicle (EV) Hype: Practical Solutions and Remaining Hurdles in EV Research, Manufacturing, and Clinical Translation","volume":"13","author":"Lundy","year":"2026","journal-title":"Adv. Sci. (Weinh. Baden. -Wurtt. Ger."},{"key":"10.1016\/j.biopha.2026.119888_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hcs2.70028","article-title":"Exploring Regulatory Frameworks for Exosome Therapy: Insights and Perspectives","volume":"4","author":"Li","year":"2025","journal-title":"Heal. Care Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib58","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41565-023-01585-y","article-title":"Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent","volume":"19","author":"Liam-Or","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-025-00922-4","article-title":"Biology and therapeutic potential of extracellular vesicle targeting and uptake","volume":"27","author":"Ripoll","year":"2026","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119888_bib60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/pharmaceutics18010066","article-title":"From Circulation to Regeneration: Blood Cell Membrane-Coated Nanoparticles as Drug Delivery Platform for Immune-Regenerative Therapy","volume":"18","author":"Kim","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib61","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1039\/D4NR00284A","article-title":"Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy","volume":"16","author":"Zhong","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119888_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.70025","article-title":"Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles","volume":"17","author":"Sundaram","year":"2025","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib63","first-page":"33","article-title":"Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy","volume":"5","author":"Guo","year":"2024","journal-title":"Biomater. Transl."},{"key":"10.1016\/j.biopha.2026.119888_bib64","article-title":"Cell Membrane-Coated Lipid Nanoparticles for Drug Delivery","volume":"6","author":"Zewail","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.biopha.2026.119888_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042071","article-title":"Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics","volume":"25","author":"Fern\u00e1ndez-Borbolla","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2026.124139","article-title":"Cell membrane-coating nanotechnology: An integrated strategy against the multifactorial pathogenesis of periodontitis","volume":"332","author":"Han","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119888_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202400012","article-title":"Cell membrane-coated nanoparticles: a new frontier in immunomodulation","volume":"4","author":"Desai","year":"2024","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.biopha.2026.119888_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2024.2361169","article-title":"Advances in cell membrane-based biomimetic nanodelivery systems for natural products","volume":"31","author":"Zhang","year":"2024","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.biopha.2026.119888_bib69","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/pharmaceutics17101322","article-title":"Cancer cell membrane-coated NPs as a biomimetic strategy for precision tumor therapy","volume":"17","author":"Lin","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib70","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.2147\/IJN.S531558","article-title":"Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases","volume":"20","author":"Zhao","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","article-title":"Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers","volume":"9","author":"Yin","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115134","article-title":"Overcoming biological barriers by virus-like drug particles for drug delivery","volume":"203","author":"Chen","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2022.102785","article-title":"Virus-like particles for drug delivery: a review of methods and applications","volume":"78","author":"Ikwuagwu","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib74","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119888_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202216097","article-title":"Protein-based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy","volume":"62","author":"Kaltbeitzel","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biopha.2026.119888_bib76","article-title":"Functionalized albumin nanoparticles: A multifunctional platform for enhanced brain drug delivery","volume":"35","author":"Mohammad","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2026.119888_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16091172","article-title":"Exploring Protein-Based Carriers in Drug Delivery: A Review","volume":"16","author":"Ferraro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122464","article-title":"Protein-based nanoparticles for therapeutic nucleic acid delivery","volume":"305","author":"Eweje","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119888_bib79","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1039\/D5CB00057B","article-title":"Advances in programmable DNA nanostructures enabling stimuli-responsive drug delivery and multimodal biosensing","volume":"6","author":"Hong","year":"2025","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119888_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115610","article-title":"DNA-Based nanostructures for tumor microenvironment-responsive drug delivery","volume":"223","author":"Li","year":"2025","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/cbe.3c00023","article-title":"DNA-Based Nanostructured Platforms as Drug Delivery Systems","volume":"1","author":"Kumar","year":"2024","journal-title":"Chem. Bio Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib82","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1021\/acs.chemrev.0c01332","article-title":"Self-Assembling Nucleic Acid Nanostructures Functionalized with Aptamers","volume":"121","author":"Krissanaprasit","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2024.2328440","article-title":"RNA nanostructures for targeted drug delivery and imaging","volume":"21","author":"Teodori","year":"2024","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2026.119888_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084458","article-title":"Applications of Metal-Organic Frameworks as Drug Delivery Systems","volume":"23","author":"Maranescu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116546","article-title":"Cyclodextrin-based metal-organic frameworks transforming drug delivery","volume":"274","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119888_bib86","doi-asserted-by":"crossref","first-page":"43156","DOI":"10.1021\/acsami.4c09536","article-title":"Research Progress of Metal-Organic Frameworks as Drug Delivery Systems","volume":"16","author":"Liu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119888_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2025.107764","article-title":"Metal-organic frameworks (MOFs): Redefining antiparasitic drug delivery","volume":"269","author":"L\u00f3pez-Monteon","year":"2025","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2026.119888_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2026.1798045","article-title":"Exploration of covalent-organic frameworks and metal-organic frameworks for drug delivery applications","volume":"14","author":"Sheng","year":"2026","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2026.119888_bib89","doi-asserted-by":"crossref","DOI":"10.1039\/D5NH00612K","article-title":"Covalent organic frameworks as precision nanocarriers for targeted drug delivery: developments, hurdles, and horizons","volume":"11","author":"Irie","year":"2026","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.biopha.2026.119888_bib90","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119888_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/srep25876","article-title":"Liposome production by microfluidics: Potential and limiting factors","volume":"6","author":"Carugo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119888_bib92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119888_bib93","article-title":"Rational design of lipid-based nanoparticles for targeted anticancer therapies","author":"Arenas-Moreira","year":"2026","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib94","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"M\u00fcller","year":"2002","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.scp.2017.07.002","article-title":"Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery","volume":"6","author":"Ganesan","year":"2017","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib96","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib97","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib98","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41587-024-02437-3","article-title":"Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313791","article-title":"Expanding RNAi to Kidneys, Lungs, and Spleen via Selective ORgan Targeting (SORT) siRNA Lipid Nanoparticles","volume":"36","author":"Vaidya","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib100","article-title":"Liposomal lipid nanoparticles for extrahepatic delivery of mRNA","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib101","doi-asserted-by":"crossref","first-page":"24302","DOI":"10.1021\/jacs.3c09143","article-title":"Modular Design of Biodegradable Ionizable Lipids for Improved mRNA Delivery and Precise Cancer Metastasis Delineation In Vivo","volume":"145","author":"Chen","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119888_bib102","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41551-024-01267-7","article-title":"Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution","volume":"8","author":"Han","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib103","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-024-45422-9","article-title":"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib105","article-title":"AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib106","article-title":"Advanced microfluidic techniques for the preparation of solid lipid nanoparticles: Innovations and biomedical applications","volume":"10","author":"Javid-Naderi","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.biopha.2026.119888_bib107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: An overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","article-title":"Chitosan-based drug delivery systems","volume":"81","author":"Bernkop-Schn\u00fcrch","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119888_bib109","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jconrel.2013.09.019","article-title":"Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research","volume":"172","author":"Elzoghby","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","article-title":"Alginate: Properties and biomedical applications","volume":"37","author":"Lee","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib111","doi-asserted-by":"crossref","DOI":"10.1039\/D6NR00511J","article-title":"Engineering molecularly imprinted polymers for receptor-specific cancer therapeutics","volume":"18","author":"Tiwari","year":"2026","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119888_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202503503","article-title":"Molecular Simulations of Polymer-based Drug Nanocarriers: From Physical and Structural Properties to Controlled Release","volume":"15","author":"Gao","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2023.101769","article-title":"Therapeutic supramolecular polymers: designs and applications","volume":"148","author":"Wang","year":"2024","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2024.12.007","article-title":"Recent advances in the bench-to-bedside translation of cancer nanomedicines","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119888_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2025.1591119","article-title":"Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation","volume":"7","author":"Amoako","year":"2025","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.biopha.2026.119888_bib116","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.xphs.2024.09.015","article-title":"Review of machine learning for lipid nanoparticle formulation and process development","volume":"113","author":"Dorsey","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib117","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.addr.2008.03.012","article-title":"Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers","volume":"60","author":"Slowing","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib118","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1002\/adma.201205292","article-title":"vivo bio-safety evaluations and diagnostic\/therapeutic applications of chemically designed mesoporous silica nanoparticles","volume":"25","author":"Chen","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib119","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/ar7002804","article-title":"Noble metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology, and medicine","volume":"41","author":"Jain","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib120","first-page":"55","article-title":"Gold Nanoparticles for Biology and Medicine","volume":"1 1","author":"Giljohann","year":"2021","journal-title":"Spherical Nucleic Acids"},{"key":"10.1016\/j.biopha.2026.119888_bib121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/smll.201000134","article-title":"A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies","volume":"7","author":"Kennedy","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.biopha.2026.119888_bib122","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1039\/C3CS60273G","article-title":"Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy","volume":"43","author":"Biju","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050878","article-title":"Advancing Cancer Therapy with Quantum Dots and Other Nanostructures: A Review of Drug Delivery Innovations, Applications, and Challenges","volume":"17","author":"Pareek","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.biopha.2026.119888_bib124","first-page":"47","article-title":"Carbon quantum dots as multifunctional nanomaterials for sustainable optoelectronic biosensing and green photonics","volume":"71","author":"Sen","year":"2026","journal-title":"Commun. Mater. 2026"},{"key":"10.1016\/j.biopha.2026.119888_bib125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.actbio.2019.05.022","article-title":"Quantum dots in biomedical applications","volume":"94","author":"Wagner","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2026.119888_bib126","article-title":"Carbon Quantum Dots in Biomedical Applications: Advances, Challenges, and Future Prospects","volume":"6","author":"Pechnikova","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.biopha.2026.119888_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/anbr.202500144","article-title":"Surface-Coated Inorganic Nanomaterials for Drug Delivery: Chemical Design, Biomedical Applications, and Mechanistic Insights","volume":"6","author":"Daneshgar","year":"2026","journal-title":"Adv. NanoBiomed Res."},{"issue":"80","key":"10.1016\/j.biopha.2026.119888_bib128","first-page":"1","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119888_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biopha.2026.119888_bib130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymthe.2020.11.030","article-title":"Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms","volume":"29","author":"Dad","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119888_bib132","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.18632\/oncotarget.4004","article-title":"Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death","volume":"6","author":"Raimondo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119888_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12266","article-title":"Comparative analysis of tangential flow filtration and ultracentrifugation, both combined with subsequent size exclusion chromatography, for the isolation of small extracellular vesicles","volume":"11","author":"Visan","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biopha.2026.119888_bib134","doi-asserted-by":"crossref","first-page":"32045","DOI":"10.1021\/acsnano.4c10381","article-title":"Extracellular Matrix Limits Nanoparticle Diffusion and Cellular Uptake in a Tissue-Specific Manner","volume":"18","author":"Cahn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib135","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biopha.2026.119888_bib136","article-title":"Leveraging nature\u2019s nanocarriers: translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-91873-5","article-title":"A synthetic model of bioinspired liposomes to study cancer-cell derived extracellular vesicles and their uptake by recipient cells","volume":"15","author":"L\u00f3pez","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119888_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115461","article-title":"Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids","volume":"215","author":"Bader","year":"2024","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib139","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcyt.2025.06.003","article-title":"Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trials","volume":"27","author":"Li","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.biopha.2026.119888_bib140","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.70003","article-title":"Orthogonal analysis reveals inconsistencies in cargo loading of extracellular vesicles","volume":"3","author":"Lowe","year":"2024","journal-title":"J. Extracell. Biol."},{"key":"10.1016\/j.biopha.2026.119888_bib141","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00216-022-04248-4","article-title":"Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles","volume":"415","author":"Chen","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biopha.2026.119888_bib142","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17425247.2025.2593981","article-title":"Recent advances in PDEVs as nanocarriers for drug delivery: loading techniques, engineering strategies and future directions","volume":"23","author":"Rajasekaran","year":"2026","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.biopha.2026.119888_bib143","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/pharmaceutics18060659","article-title":"Engineering strategies for plant-derived extracellular vesicles: modification, drug delivery performance, and synergistic effects with gel composite systems","volume":"18","author":"Qiu","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics18050577","article-title":"Engineered Plant-Derived Extracellular Vesicles: A Novel Strategy for Tumor-Targeted Therapy","volume":"18","author":"Zuo","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib145","doi-asserted-by":"crossref","first-page":"14201","DOI":"10.2147\/IJN.S567188","article-title":"Engineering Biomimetic Nanoplatforms for Acute Lung Injury: From Mechanistic Insights to Translational Opportunities","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib146","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1039\/D3NJ05187K","article-title":"ZIF-90-decorated silica nanoparticles with a spiky surface: a novel approach to drug delivery","volume":"48","author":"Sharma","year":"2024","journal-title":"New. J. Chem."},{"key":"10.1016\/j.biopha.2026.119888_bib147","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s12272-022-01413-2","article-title":"Enhancement of S(+)-zaltoprofen oral bioavailability using nanostructured lipid carrier system","volume":"45","author":"Pham","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib148","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.2147\/IJN.S372477","article-title":"Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancer","volume":"17","author":"Kosaka","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib149","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib151","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib152","doi-asserted-by":"crossref","first-page":"13223","DOI":"10.1039\/D5RA09247G","article-title":"Advances in NP shapes and their applications in cancer therapy","volume":"16","author":"Li","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib153","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119888_bib154","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib156","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","article-title":"Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases","volume":"41","author":"Low","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib157","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2026.119888_bib158","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","article-title":"Therapeutic antibodies: successes, limitations and hopes for the future","volume":"157","author":"Chames","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119888_bib159","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1002\/adma.201200454","article-title":"Peptides as targeting elements and tissue penetration devices for nanoparticles","volume":"24","author":"Ruoslahti","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib160","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: Design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib161","doi-asserted-by":"crossref","first-page":"19667","DOI":"10.1021\/acsnano.3c02575","article-title":"Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells","volume":"17","author":"Carney","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/nano15030158","article-title":"Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting","volume":"15","author":"Spada","year":"2025","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2026.119888_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102237","article-title":"Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles","volume":"14","author":"Thomsen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib164","article-title":"Advances in phenylboronic acid and phenylboronic ester-based responsive systems for precision medicine","author":"Nair","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113991","article-title":"Clinical cancer nanomedicines","volume":"385","author":"Pallares","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib166","doi-asserted-by":"crossref","first-page":"9494","DOI":"10.1039\/C4NR00708E","article-title":"Nanoparticles for photothermal therapies","volume":"6","author":"Jaque","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119888_bib167","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addr.2013.11.008","article-title":"Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms","volume":"72","author":"Lentacker","year":"2014","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib168","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2016.06.012","article-title":"Nanomedicine of synergistic drug combinations for cancer therapy \u2013 strategies and perspectives","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib169","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119888_bib170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119888_bib171","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib172","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nantod.2012.06.013","article-title":"Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance","volume":"7","author":"Creixell","year":"2012","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2026.119888_bib173","doi-asserted-by":"crossref","first-page":"18638","DOI":"10.1073\/pnas.1303958110","article-title":"Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug","volume":"110","author":"Xu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119888_bib174","doi-asserted-by":"crossref","first-page":"13983","DOI":"10.1021\/acsnano.4c00182","article-title":"Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions","volume":"18","author":"Anchordoquy","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib175","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122661","article-title":"Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers","volume":"634","author":"Pangeni","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib177","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/acsbiomaterials.2c00047","article-title":"Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier","volume":"8","author":"Watchorn","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115051","article-title":"Progress on the pathological tissue microenvironment barrier-modulated nanomedicine","volume":"200","author":"Han","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib179","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03815-y","article-title":"Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy","volume":"23","author":"Gong","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119888_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib182","article-title":"Nanomedicine Reimagined: Translational Strategies for Precision Tumor Theranostics","volume":"38","author":"Wu","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib183","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.2147\/IJN.S554821","article-title":"Bridging the Gap: The Role of Advanced Formulation Strategies in the Clinical Translation of Nanoparticle-Based Drug Delivery Systems","volume":"20","author":"Herdiana","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115946","article-title":"Advances in targeted therapeutics and smart delivery systems based on precision nano-oncology","volume":"169","author":"Ma","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2026.119888_bib185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/D5PM00179J","article-title":"Advancements in nano-based drug delivery systems for therapeutics: A comprehensive review","volume":"3","author":"John","year":"2026","journal-title":"RSC Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1734570","article-title":"Smart nanoplatforms for early detection and immune modulation in lung cancer","volume":"13","author":"Yu","year":"2026","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib187","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.7150\/thno.128136","article-title":"Biomimetic cell membrane-coated nanovaccines in anti-tumor immunotherapy","volume":"16","author":"Chen","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119888_bib188","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12272-026-01609-w","article-title":"Recent paclitaxel formulation strategies: Expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations","volume":"49","author":"Lee","year":"2026","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib189","doi-asserted-by":"crossref","unstructured":"L. Zeng, Propensity-matched study of liposomal doxorubicin vs, Doxorubicin First-Line DLBCL Treat. Effic. Safety. Front Med 13 (n.d.) 1769270.","DOI":"10.3389\/fmed.2026.1769270"},{"key":"10.1016\/j.biopha.2026.119888_bib190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-026-02608-5","article-title":"Chemo-photothermal synergy ignites antitumor immunity via ferroptosis","volume":"11","author":"Lin","year":"2026","journal-title":"Sig Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119888_bib191","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/ijms27010248","article-title":"Hybrid nanocarriers for cancer therapy: Advancements in co-delivery of gene therapy and immunotherapy","volume":"27","author":"Berikkhanova","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib192","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S573093","article-title":"Nanoparticle-enabled photothermal therapy integrated with gene delivery, immunotherapy, and chemotherapy: a comprehensive review","volume":"21","author":"Hwang","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib193","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/pharmaceutics14081581","article-title":"Recent advances in nanoparticles-based platforms targeting the PD-1\/PD-L1 pathway for cancer treatment","volume":"14","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics18040485","article-title":"The next wave of immunotherapy: a critical review of nanotechnology strategies for immune checkpoint blockade","volume":"18","author":"Almuqbil","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12964-025-02610-4","article-title":"Advanced nanotechnology in enhancing immune checkpoint inhibitors (ICIs) for head and neck cancer therapy","volume":"24","author":"Jafari","year":"2025","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.biopha.2026.119888_bib196","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib197","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2147\/IJN.S285999","article-title":"Combination cancer immunotherapy of nanoparticle-based immunogenic cell death inducers and immune checkpoint inhibitors","volume":"16","author":"Qi","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib198","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12499","article-title":"Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib199","article-title":"Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy","volume":"49","author":"Li","year":"2026","journal-title":"Cell. Oncol. (Dordrecht Netherlands)"},{"key":"10.1016\/j.biopha.2026.119888_bib200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.32607\/actanaturae.27707","article-title":"mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes","volume":"17","author":"Ibragimova","year":"2025","journal-title":"Acta Nat."},{"key":"10.1016\/j.biopha.2026.119888_bib201","doi-asserted-by":"crossref","first-page":"15795","DOI":"10.1021\/acs.nanolett.5c03826","article-title":"Advancing Lung Cancer Treatment: mRNA Therapeutics and Delivery Strategies","volume":"25","author":"Yaremenko","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2026.119888_bib202","unstructured":"Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat breast cancer, Nature (2026). https:\/\/doi.org\/10.1038\/D41586-026-00477-0;SUBJMETA."},{"key":"10.1016\/j.biopha.2026.119888_bib203","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119888_bib204","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-026-00899-y","article-title":"vivo engineering of CAR-T cells: delivery strategies and clinical translation","volume":"14","author":"Gao","year":"2026","journal-title":"Biomark. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib205","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/sciadv.adz1722","article-title":"Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion","volume":"12","author":"Jain","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib206","doi-asserted-by":"crossref","unstructured":"L. Hao, J. Lu, J. Xue, In vivo CAR-T therapy for cancer treatment: Mechanisms, technological advances, and clinical translation, Oncol Res 34 (n.d.) 10.","DOI":"10.32604\/or.2026.076420"},{"key":"10.1016\/j.biopha.2026.119888_bib207","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S563233","article-title":"Deep tumor penetration using nanoparticle delivery systems: Programmed design strategies and emerging evaluation platforms","volume":"21","author":"Javan","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib208","doi-asserted-by":"crossref","DOI":"10.1007\/s40268-026-00538-9","article-title":"Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood\u2013Brain Barrier","author":"Lei","year":"2026","journal-title":"Drugs R. D."},{"key":"10.1016\/j.biopha.2026.119888_bib209","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10408398.2017.1363714","article-title":"Natural phospholipids: Occurrence, biosynthesis, separation, identification, and beneficial health aspects","volume":"59","author":"Ali","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.biopha.2026.119888_bib210","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S597376","article-title":"Preclinical Nanoparticle Approaches Targeting Tumor-Associated Macrophages in Breast Cancer: From Mechanisms to Therapeutic Strategies","volume":"21","author":"Teng","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib211","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S570411","article-title":"Nanomedicines reshape the tumor microenvironment: Multidimensional strategies from modulating \u201cbarriers\u201d to metabolic intervention","volume":"21","author":"Zhao","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib212","article-title":"From permeation enhancer to therapeutic enabler: Advances, applications, and translational perspectives in hyaluronidase-based drug delivery","volume":"38","author":"Seo","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2026.119888_bib213","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cell.2025.12.008","article-title":"Nanoparticles hijack calvarial immune cells for CNS drug delivery and stroke therapy","volume":"189","author":"Gao","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119888_bib214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms27052370","article-title":"From Polyphenols to Prodrugs: Bridging the Blood-Brain Barrier with Nanomedicine and Neurotherapeutics","volume":"27","author":"Tanaka","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib215","first-page":"1","article-title":"Targeted Nanoparticles for Drug Delivery Across the Blood-Brain Barrier in Early and Late Stages of Alzheimer\u2019s Disease: A Review","volume":"63","author":"Kochman","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119888_bib216","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03572-y","article-title":"Recent advances of engineering cell membranes for nanomedicine delivery across the blood\u2013brain barrier","volume":"23","author":"Yuan","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2025.5789","article-title":"Nanoparticle\u2011based delivery systems for targeted therapy in brain tumors: progress, challenges and perspectives (Review)","volume":"67","author":"Si","year":"2025","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2026.119888_bib218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2025.1674333","article-title":"Skeleton keys and trojan horses: A review of therapeutic delivery to the brain","volume":"13","author":"Stoub","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119888_bib219","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2026.2660007","article-title":"Angiopep-2-decorated bacterial outer membrane vesicles penetrate the blood-brain barrier for glioblastoma chemo-immunotherapy","volume":"33","author":"Shah","year":"2026","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.biopha.2026.119888_bib220","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/polym14040712","article-title":"Angiopep-2-modified nanoparticles for brain-directed delivery of therapeutics: A review","volume":"14","author":"Habib","year":"2022","journal-title":"Polym"},{"key":"10.1016\/j.biopha.2026.119888_bib221","first-page":"1","article-title":"Optimizing Angiopep-2 Density on Polymeric Nanoparticles for Enhanced Blood\u2013Brain Barrier Penetration and Glioblastoma Targeting: Insights From In Vitro and In Vivo Experiments","volume":"35","author":"Zhang","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17091169","article-title":"Cracking the Blood-Brain Barrier Code: Rational Nanomaterial Design for Next-Generation Neurological Therapies","volume":"17","author":"N\u00e1jera-Maldonado","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib223","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.cell.2026.01.031","article-title":"Harnessing skull immunity for brain drug delivery","volume":"189","author":"McCullough","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119888_bib224","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/imr.13120","article-title":"The emergence of the calvarial hematopoietic niche in health and disease","volume":"311","author":"Mills","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib225","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0271678X251316392","article-title":"Evidence for cellular and solute passage between the brain and skull bone marrow across meninges: A systematic review","volume":"45","author":"Eide Therkelsen","year":"2025","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.biopha.2026.119888_bib226","doi-asserted-by":"crossref","DOI":"10.1109\/EMBC53108.2024.10782662","article-title":"Hitchhiking calvaria immune cells to bypass BBB for CNS drug delivery through transcranial nanoparticle microinjection","author":"Gao","year":"2024","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. IEEE Eng. Med. Biol. Soc. Annu. Int. Conf. 2024"},{"key":"10.1016\/j.biopha.2026.119888_bib227","doi-asserted-by":"crossref","first-page":"37540","DOI":"10.1039\/D5RA03599F","article-title":"Cerium-based nanoparticles for neurodegeneration: emerging redox therapeutics beyond pharmaceuticals","volume":"15","author":"Mishra","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib228","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/D5BM01080B","article-title":"Engineering microglial exosome-mediated microRNA-124-3p delivery for Alzheimer\u2019s disease combinational therapy","volume":"14","author":"Ke","year":"2026","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2025.102671","article-title":"Nose-to-brain siRNA delivery by PEI\/PPI-based nanoparticles reduces \u03b1-synuclein expression in a Parkinson\u2019s disease mouse model","volume":"36","author":"Feja","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2026.119888_bib230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jconrel.2024.11.069","article-title":"Delivery of small interfering RNA by hydrogen sulfide-releasing nanomotor for the treatment of Parkinson\u2019s disease","volume":"377","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib231","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1039\/D5NA00593K","article-title":"A novel nanocomposite Lf-DA-MSN-PF127 aided the delivery of dopamine for the treatment of Parkinson\u2019s disease in a rat model","volume":"7","author":"Hanumanthappa","year":"2025","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib232","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phymed.2025.156547","article-title":"Lactoferrin-modified organic-inorganic hybrid mesoporous silica for co-delivery of levodopa and curcumin in the synergistic treatment of Parkinson\u2019s disease","volume":"140","author":"Guo","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119888_bib233","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/20415990.2024.2415281","article-title":"Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies","volume":"16","author":"Dhiman","year":"2025","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biopha.2026.119888_bib234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13020195","article-title":"Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: an update","volume":"13","author":"Hsu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119888_bib235","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17040701","article-title":"Progress in drug delivery systems based on nanoparticles for improved glioblastoma therapy: addressing challenges and investigating opportunities","volume":"17","author":"Rahman","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119888_bib236","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-08083-0","article-title":"GSCs differentiation model-informed nanotherapy: dual-functional brain-targeting liposomes with iRGD modification for co-delivery of osimertinib and bortezomib to combat radioresistant glioblastoma","volume":"16","author":"Xie","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119888_bib237","article-title":"Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme","volume":"6","author":"Angom","year":"2026","journal-title":"Commun. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib238","article-title":"Dual molecularly imprinted nanocomposite with transferrin mediated glioma targeting and cholesterol exhaustion for synergistic cuproptosis\/immune checkpoint blockade\/immunogenic cell death","volume":"34","author":"Zhao","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2026.119888_bib239","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03688-1","article-title":"Quadruple synergistic amplification of ferroptosis for precision glioblastoma therapy: a luteolin-coordinated ferric ion nanoplatform","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib240","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1007\/s10072-025-08457-4","article-title":"Advancing glioblastoma therapy with surface-modified nanoparticles","volume":"46","author":"De Rosa","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115759","article-title":"Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma","volume":"229","author":"Zam","year":"2026","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib242","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13060601","article-title":"mRNA Vaccine Technology Beyond COVID-19","volume":"13","author":"Oloruntimehin","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2026.119888_bib243","article-title":"Recent advances in lipid nanoparticles for cancer vaccine delivery: Challenges and future perspectives","volume":"11","author":"Hasan","year":"2026","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.biopha.2026.119888_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102499","article-title":"Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery","volume":"81","author":"Zhao","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119888_bib245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-026-04383-5","article-title":"Mechanistic insights into mRNA-LNP interactions: role of ionizable lipid content in regulating mRNA intracellular release and translation","volume":"24","author":"Truong","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib246","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-026-02512-x","article-title":"Crosslinked ionizable lipids reprogram dendritic cell metabolism for potent mRNA vaccination","author":"Kim","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib247","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.7150\/ijbs.125206","article-title":"Metabolic checkpoints in CD8+ T cells within the tumor microenvironment: a comprehensive review and emerging insights","volume":"22","author":"Ai","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib248","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/pharmaceutics14020382","article-title":"Nanotechnology as a versatile tool for 19F-MRI agent\u2019s formulation: a glimpse into the use of perfluorinated and fluorinated compounds in nanoparticles","volume":"14","author":"Joseph","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114038","article-title":"Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types","volume":"386","author":"Gustafsson","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib250","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202401632","article-title":"Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components","volume":"10","author":"Wu","year":"2026","journal-title":"Small Methods"},{"key":"10.1016\/j.biopha.2026.119888_bib251","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","article-title":"Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations","volume":"9","author":"Ho\u0142ubowicz","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib252","article-title":"Spatiotemporally regulated mitochondrial genome editing via enzyme and NIR-activated CRISPR\/Cas9 nanoplatform","volume":"17","author":"Yang","year":"2026","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib253","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1056\/NEJMoa2405734","article-title":"CRISPR-Based Therapy for Hereditary Angioedema","volume":"392","author":"Cohn","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib254","first-page":"1","article-title":"Nanoparticle drug delivery systems for atherosclerosis: precision targeting, inflammatory modulation, and plaque stabilization","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib255","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.7150\/thno.106991","article-title":"Recent progress in ROS-responsive biomaterials for the diagnosis and treatment of cardiovascular diseases","volume":"15","author":"Yuan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119888_bib256","doi-asserted-by":"crossref","first-page":"43374","DOI":"10.1021\/acsami.3c07371","article-title":"Shear Stress and ROS Dual-Responsive RBC-Hitchhiking Nanoparticles for Atherosclerosis Therapy","volume":"15","author":"Shen","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119888_bib257","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071720","article-title":"Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies","volume":"13","author":"Bartusik-Aebisher","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119888_bib258","doi-asserted-by":"crossref","first-page":"37562","DOI":"10.1021\/acsami.5c05638","article-title":"The Role of Acoustic Parameters in Droplet Vaporization of Perfluoropentane Nanodroplets for In Vivo Applications","volume":"17","author":"Eom","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119888_bib259","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2026.1777056","article-title":"Precision-targeted nanodelivery systems for intra-articular treatment of knee osteoarthritis: recent breakthroughs and translational challenges","volume":"14","author":"Zhao","year":"2026","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib260","article-title":"CD11b-modified ROS\/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment","volume":"34","author":"Xu","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2026.119888_bib261","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.2147\/IJN.S503445","article-title":"How Advanced are Conductive Nanocomposite Hydrogels for Repairing and Monitoring Myocardial Infarction?","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"80","key":"10.1016\/j.biopha.2026.119888_bib262","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119888_bib263","first-page":"1","article-title":"Novel Dual Strategy Based on EPR\/AT for Optimizing Therapeutic Effect by Improving Drug Delivery System Physicochemical Properties and Regulating TME","volume":"21","author":"Chen","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib264","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1021\/acsnanoscienceau.4c00040","article-title":"Nanoparticles Codelivering mRNA and SiRNA for Simultaneous Restoration and Silencing of Gene\/Protein Expression In Vitro and In Vivo","volume":"4","author":"Manturthi","year":"2024","journal-title":"ACS Nanosci. Au"},{"key":"10.1016\/j.biopha.2026.119888_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2023.111586","article-title":"Curcumin-loaded a-lactalbumin nanoparticles neuroprotective effects against permethrine-induced neurotoxicity","volume":"158","author":"Paulpandi","year":"2023","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib266","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202523005","article-title":"Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease","volume":"38","author":"Gao","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib267","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4070\/kcj.2025.0022","article-title":"Exosome-based therapy in cardiovascular diseases: a new frontier in cardiovascular disease treatment","volume":"55","author":"Chae","year":"2025","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.biopha.2026.119888_bib268","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12951-026-04076-z","article-title":"Platelet-rich plasma-derived extracellular vesicles delivered niraparib for ultrasound imaging and atherosclerosis treatment","volume":"24","author":"Fang","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib269","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.2147\/IJN.S546817","article-title":"Macrophage membrane-coated nanocarriers in myocardial infarction: a paradigm shift in targeted cardiac therapy","volume":"20","author":"Wang","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib270","article-title":"Messenger RNA delivery to islet \u03b2 cells using conjugated lipid nanoparticles","volume":"7","author":"Enriquez","year":"2026","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib271","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1007\/s13346-025-01843-7","article-title":"Unlocking the potential of remdesivir: innovative approaches to drug delivery","volume":"15","author":"Taha","year":"2025","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib272","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","article-title":"Combinatorial development of nebulized mRNA delivery formulations for the lungs","volume":"19","author":"Jiang","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib273","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202570040","article-title":"Lipid Nanoparticle-Mediated CRISPR-Cas13a Delivery for the Control of Bacterial Infection","volume":"14","author":"Kim","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib274","first-page":"1","article-title":"Biomimetic metal-drug coordination nanoplatform to counteract drug resistance in Pseudomonas aeruginosa via energy disruption","volume":"17","author":"Ye","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib275","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgag092","article-title":"A STING-adjuvanted outer membrane vesicle nanoparticle vaccine vs. Klebsiella pneumoniae elicits broad capsule-type cross-protection","volume":"5","author":"Besan\u00e7on","year":"2026","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.biopha.2026.119888_bib276","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S592135","article-title":"Application and advances of cell membrane-coated nanoparticles in diabetic wound healing","volume":"21","author":"Sui","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102898","article-title":"The landscape of nanomedical clinical trials","volume":"66","author":"Gultepe","year":"2026","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2026.119888_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib279","first-page":"201","article-title":"The mechanisms of nanoparticle delivery to solid tumours","author":"Nguyen","year":"2024","journal-title":"Nat. Rev. Bioeng. 2024 23 2"},{"key":"10.1016\/j.biopha.2026.119888_bib280","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1704814","article-title":"How do nanoparticle properties shape pharmacokinetics and pharmacodynamics? A mechanistic review","volume":"16","author":"Peralta-Cuevas","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119888_bib281","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2026.119888_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2024.100533","article-title":"Bridging the gap: Innovative human-based in vitro approaches for nanomaterials hazard assessment and their role in safe and sustainable by design, risk assessment, and life cycle assessment","volume":"36","author":"Wu","year":"2024","journal-title":"NanoImpact"},{"key":"10.1016\/j.biopha.2026.119888_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114356","article-title":"The effects of protein corona on in vivo fate of nanocarriers","volume":"186","author":"Xiao","year":"2022","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib284","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41578-023-00552-2","article-title":"The protein corona from nanomedicine to environmental science","volume":"8","author":"Mahmoudi","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib285","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103046","article-title":"Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery","volume":"85","author":"Chou","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib286","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122605","article-title":"Biological features of nanoparticles: protein corona formation and interaction with the immune system","volume":"14","author":"Panico","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119888_bib287","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41565-023-01455-7","article-title":"Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona","volume":"18","author":"Tang","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib288","article-title":"Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib289","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1021\/acsnano.4c08922","article-title":"Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles","volume":"18","author":"Hulugalla","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib290","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib291","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119888_bib292","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib293","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2023.11.006","article-title":"Activation of the complement system by nanoparticles and strategies for complement inhibition","volume":"193","author":"Haroon","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119888_bib294","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41565-023-01514-z","article-title":"Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins","volume":"19","author":"Li","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214662","article-title":"Nanomaterial-based strategies to modulate macrophage polarization in osteoarthritis: A systematic review","volume":"181","author":"Codispoti","year":"2026","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118360","article-title":"Nanomaterial-driven macrophage polarization: Emerging strategies for immunomodulation and regenerative medicine","volume":"190","author":"Dahri","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119888_bib297","doi-asserted-by":"crossref","first-page":"21221","DOI":"10.1021\/acsnano.4c04614","article-title":"Nano-mechanical Immunoengineering: Nanoparticle Elasticity Reprograms Tumor-Associated Macrophages via Piezo1","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib298","article-title":"Impact of Nanoparticle Physicochemical Properties on Protein Corona and Macrophage Polarization","author":"Xiao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces 15"},{"key":"10.1016\/j.biopha.2026.119888_bib299","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1039\/D3NH00198A","article-title":"Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake","volume":"8","author":"Deuker","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.biopha.2026.119888_bib300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2023.09.003","article-title":"Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients","volume":"363","author":"Miao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib301","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1039\/D0AN00633E","article-title":"Engineering at the nano-bio interface: Harnessing the protein corona towards nanoparticle design and function","volume":"145","author":"Pinals","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.biopha.2026.119888_bib302","doi-asserted-by":"crossref","first-page":"481","DOI":"10.26599\/NBE.2025.9290129","article-title":"Evaluating Nanoparticle-Induced Cytotoxicity: Mechanisms and Methods","volume":"17","author":"Maria","year":"2025","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib303","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030703","article-title":"Metal-Based Nanoparticles and Their Relevant Consequences on Cytotoxicity Cascade and Induced Oxidative Stress","volume":"12","author":"Min","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119888_bib304","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1080\/17435889.2025.2571024","article-title":"Innate immuno-response to nanoparticle uptake in liver and spleen mimics pathogen infection","volume":"20","author":"Brodin","year":"2025","journal-title":"Nanomed. (Lond. )"},{"key":"10.1016\/j.biopha.2026.119888_bib305","first-page":"214","article-title":"Controlling the biodistribution and clearance of nanomedicines","volume":"2","author":"Cabral","year":"2023","journal-title":"Nat. Rev. Bioeng. 2023 23"},{"key":"10.1016\/j.biopha.2026.119888_bib306","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1039\/D3NA01097J","article-title":"Safe nanomaterials: from their use, application, and disposal to regulations","volume":"6","author":"Ch\u00e1vez-Hern\u00e1ndez","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.biopha.2026.119888_bib307","doi-asserted-by":"crossref","first-page":"34615","DOI":"10.1021\/acsnano.4c09387","article-title":"Magnetic Resonance Imaging-Based Radiogenomic Analysis Reveals Genomic Determinants for Nanoparticle Delivery into Tumors","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib308","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-45254-7","article-title":"Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery","volume":"15","author":"Miao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib309","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301067120","article-title":"Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm","volume":"120","author":"Zheng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119888_bib310","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1021\/acsnano.3c09027","article-title":"An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids","volume":"18","author":"Narum","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib311","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119888_bib312","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303567120","article-title":"Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines","volume":"120","author":"Shepherd","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119888_bib313","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/acsnano.4c12965","article-title":"Robust, Scalable Microfluidic Manufacturing of RNA-Lipid Nanoparticles Using Immobilized Antifouling Lubricant Coating","volume":"19","author":"Hwang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119888_bib314","article-title":"Exploring the Long-Term Tissue Accumulation and Excretion of 3 nm Cerium Oxide Nanoparticles after Single Dose Administration","volume":"12","author":"Ernst","year":"2023","journal-title":"Antioxid. (Basel Switz. )"},{"key":"10.1016\/j.biopha.2026.119888_bib315","unstructured":"ICH Official web site: ICH, (n.d.). https:\/\/www.ich.org\/page\/quality-guidelines (accessed August 9, 2026)."},{"key":"10.1016\/j.biopha.2026.119888_bib316","unstructured":"Multidisciplinary guidelines: nanomedicines | European Medicines Agency (EMA), (n.d.). https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/scientific-guidelines\/multidisciplinary-guidelines\/multidisciplinary-guidelines-nanomedicines (accessed August 9, 2026)."},{"key":"10.1016\/j.biopha.2026.119888_bib317","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.xphs.2024.09.005","article-title":"Current state of nanomedicine drug products: An industry perspective","volume":"113","author":"Clogston","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119888_bib318","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jconrel.2024.04.003","article-title":"Strategic aspects for the commercialization of nanomedicines","volume":"369","author":"Hemmrich","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119888_bib319","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1544393","article-title":"Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks","volume":"12","author":"Rodr\u00edguez-G\u00f3mez","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib320","unstructured":"Drug Products, Including Biological Products, that Contain Nanomaterials - Guidance for Industry | FDA, n.d. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/drug-products-including-biological-products-contain-nanomaterials-guidance-industry?utm_source=chatgpt.com (accessed August 8, 2026)."},{"key":"10.1016\/j.biopha.2026.119888_bib321","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2026.100611","article-title":"Sample preparation now (2025) and then: Lessons from 13 years of nanomaterial regulatory safety testing","volume":"41","author":"Rasmussen","year":"2026","journal-title":"NanoImpact"},{"key":"10.1016\/j.biopha.2026.119888_bib322","doi-asserted-by":"crossref","unstructured":"OECD\/OCDE, Test No. 126: Determination of the Hydrophobicity Index of Nanomaterials Through an Affinity Measurement, OECD Publishing, 2023. https:\/\/doi.org\/10.1787\/AE9C0FD1-EN.","DOI":"10.1787\/ae9c0fd1-en"},{"key":"10.1016\/j.biopha.2026.119888_bib323","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 125: Nanomaterial Particle Size and Size Distribution of Nanomaterials, OECD Guidel. Test. Chem. Sect. 1 (2023). https:\/\/doi.org\/10.1787\/AF5F9BDA-EN.","DOI":"10.1787\/af5f9bda-en"},{"key":"10.1016\/j.biopha.2026.119888_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125202","article-title":"Navigating translational research in nanomedicine: a strategic guide to formulation and manufacturing","volume":"671","author":"Zhang","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib325","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119888_bib326","first-page":"99","article-title":"Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer","author":"Miele","year":"2009","journal-title":"Int. J. Nanomed. 4"},{"key":"10.1016\/j.biopha.2026.119888_bib327","unstructured":"K. Leishear, A. Division, W. Hua, Epidemiology: ARIA Sufficiency Memo: Onpattro (patisiran) Subject: Active Risk Identification and Assessment (ARIA) Sufficiency Memo for Pregnancy Safety Concerns, (2018). https:\/\/www.nice.org.uk\/guidance\/gid-hst10013\/documents\/draft-scope-pre-referral (accessed June 27, 2026)."},{"key":"10.1016\/j.biopha.2026.119888_bib328","first-page":"277","article-title":"Liposomal daunorubicin as treatment for Kaposi\u2019s sarcoma","volume":"2","author":"Petre","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119888_bib329","doi-asserted-by":"crossref","first-page":"e1414","DOI":"10.1634\/theoncologist.2019-0785","article-title":"EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX-351) for the Treatment of Adults with Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes","volume":"25","author":"Tzogani","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.biopha.2026.119888_bib330","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib331","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib332","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib333","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41416-019-0391-z","article-title":"A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients","volume":"120","author":"Fujiwara","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119888_bib334","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2385-z","article-title":"HERMIONE: A randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician\u2019s choice plus trastuzumab in patients with previously treated, anthracycline-na\u00efve, HER2-positive, locally advanced\/metastatic breast cancer","volume":"16","author":"Miller","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119888_bib335","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1039\/D6CS00165C","article-title":"Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics","volume":"55","author":"Kobzev","year":"2026","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2026.119888_bib336","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119888_bib337","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-019-0329-7","article-title":"Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: \u201cDrug Products, Including Biological Products, that Contain Nanomaterials","volume":"21","author":"de Vlieger","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2026.119888_bib338","unstructured":"ICH, ICH HARMONISED GUIDELINE QUALITY RISK MANAGEMENT Q9(R1), 2023."},{"key":"10.1016\/j.biopha.2026.119888_bib339","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","article-title":"Regulating nanomedicines: challenges, opportunities, and the path forward","volume":"20","author":"Mangla","year":"2025","journal-title":"Nanomed. (Lond. )"},{"key":"10.1016\/j.biopha.2026.119888_bib340","unstructured":"U. MHRA, Decision tree for navigating nanotechnology-based products for medical application, (2025). https:\/\/www.gov.uk\/government\/publications\/decision-tree-for-navigating-nanotechnology-based-products-for-medical-application (accessed August 8, 2026)."},{"key":"10.1016\/j.biopha.2026.119888_bib341","unstructured":"ICH guidelines: Quality | European Medicines Agency (EMA), n.d. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/scientific-guidelines\/ich-guidelines\/ich-guidelines-quality (accessed August 8, 2026)."},{"key":"10.1016\/j.biopha.2026.119888_bib342","first-page":"10","article-title":"The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin Amyloidosis","volume":"25","author":"Mickle","year":"2019","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.biopha.2026.119888_bib343","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102362","article-title":"Profiling patent compounds in lipid nanoparticle formulations of siRNA","volume":"35","author":"Han","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2026.119888_bib344","first-page":"1","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","author":"Witten","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119888_bib345","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41551-023-01030-4","article-title":"Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery","volume":"7","author":"Rhym","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119888_bib346","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100996","article-title":"Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost\/Bayesian method and ensemble model approaches","volume":"14","author":"Maharjan","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.biopha.2026.119888_bib347","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1039\/D5DD00171D","article-title":"Efficient discovery of new medicine formulations using a semi-self-driven robotic formulator","volume":"4","author":"Ros","year":"2025","journal-title":"Digit. Discov."},{"key":"10.1016\/j.biopha.2026.119888_bib348","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218158","article-title":"Integrated multi-omics analyses identified the H3K18la-based spatiotemporal characteristics and risk-stratified treatment strategy in lung adenocarcinoma","volume":"638","author":"Shen","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119888_bib349","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.315","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.biopha.2026.119888_bib350","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biopha.2026.119888_bib351","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-024-01402-3","article-title":"Challenges and opportunities for digital twins in precision medicine from a complex systems perspective","volume":"8","author":"De Domenico","year":"2025","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib352","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib353","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-022-00694-7","article-title":"Health digital twins as tools for precision medicine: Considerations for computation, implementation, and regulation","volume":"5","author":"Venkatesh","year":"2022","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.biopha.2026.119888_bib354","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002349","article-title":"Smart nanofluidic systems powered by DNA origami for targeted intracellular delivery: a newer approach","volume":"6","author":"Singh","year":"2025","journal-title":"Explor. Target. Anti-Tumor Ther."},{"key":"10.1016\/j.biopha.2026.119888_bib355","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1186\/s12967-025-07101-1","article-title":"Plant-derived extracellular vesicles: composition, function and clinical potential","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:09:27Z","timestamp":1790082567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":355,"alternative-id":["S0753332226009248"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119888","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomaterial-based drug delivery systems: From intelligent delivery to clinical translation and precision nanomedicine","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119888"}}